- Home
- LIPO vs MTNB Comparison
LIPO vs MTNB Comparison
Compare LIPO & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- MTNB
- Stock Information
- Founded
- LIPO 2005
- MTNB 2013
- Country
- LIPO United States
- MTNB United States
- Employees
- LIPO N/A
- MTNB N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- LIPO Health Care
- MTNB Health Care
- Exchange
- LIPO Nasdaq
- MTNB Nasdaq
- Market Cap
- LIPO 3.8M
- MTNB 3.6M
- IPO Year
- LIPO 2022
- MTNB N/A
- Fundamental
- Price
- LIPO $2.85
- MTNB $0.57
- Analyst Decision
- LIPO Strong Buy
- MTNB Hold
- Analyst Count
- LIPO 1
- MTNB 1
- Target Price
- LIPO $16.00
- MTNB N/A
- AVG Volume (30 Days)
- LIPO 91.5K
- MTNB 960.1K
- Earning Date
- LIPO 02-25-2025
- MTNB 11-13-2024
- Dividend Yield
- LIPO N/A
- MTNB N/A
- EPS Growth
- LIPO N/A
- MTNB N/A
- EPS
- LIPO N/A
- MTNB N/A
- Revenue
- LIPO $483,533.00
- MTNB N/A
- Revenue This Year
- LIPO N/A
- MTNB N/A
- Revenue Next Year
- LIPO N/A
- MTNB N/A
- P/E Ratio
- LIPO N/A
- MTNB N/A
- Revenue Growth
- LIPO 0.78
- MTNB N/A
- 52 Week Low
- LIPO $2.21
- MTNB $0.48
- 52 Week High
- LIPO $12.00
- MTNB $21.50
- Technical
- Relative Strength Index (RSI)
- LIPO 45.72
- MTNB 44.59
- Support Level
- LIPO $2.78
- MTNB $0.55
- Resistance Level
- LIPO $3.17
- MTNB $0.99
- Average True Range (ATR)
- LIPO 0.29
- MTNB 0.16
- MACD
- LIPO -0.04
- MTNB 0.01
- Stochastic Oscillator
- LIPO 7.61
- MTNB 9.98
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.